Iotalamic acid

Iotalamic acid
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	V08AA04 (WHO) ;
Identifiers
	IUPAC name 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;
PubChem CID	3737;
ChemSpider	3606;
UNII	16CHD79MIX;
KEGG	D01258;
CompTox Dashboard (EPA)	DTXSID5023164 ;
ECHA InfoCard	100.017.181
Chemical and physical data
Formula	C11H9I3N2O4
Molar mass	613.91357 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I;
	InChI InChI=1S/C11H9I3N2O4/c1-3(17)16-9-7(13)4(10(18)15-2)6(12)5(8(9)14)11(19)20/h1-2H3,(H,15,18)(H,16,17)(H,19,20); Key:UXIGWFXRQKWHHA-UHFFFAOYSA-N;

Iotalamic acid (also iothalamic acid in USAN) and its salts (INN Iothalamates) is an iodine-containing organic anion used as a radiocontrast agent. It is available as sodium iothalamate (Iothalamate sodium) and meglumine iothalamate (Iothalmate meglumine). It can be administered intravenously or intravesically (into the urinary bladder).^[1]

Radioactive formulation is also available as sodium iothalamate I-125 Injection (GLOFIL-125). It is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.^[1]

References

^ ^a ^b "Iothalamate Meglumine and Iothalamate Sodium Drug Information, Professional". www.drugs.com. Retrieved 2016-07-16.

This chemistry-related article is a stub. You can help Wikipedia by expanding it.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[dru-1] "Iothalamate Meglumine and Iothalamate Sodium Drug Information, Professional". www.drugs.com. Retrieved 2016-07-16.

[1]